Buy Alert: 3 Pot Stocks That Can Double Again in 2021!

Cannabis investors can consider adding growth stocks such as Green Thumb Industries to their portfolio right now.

| More on:
edit Jars of marijuana

Image source: Getty Images

In the last year, pot stocks south of the border have crushed broader market returns. Stocks such as Green Thumb Industries (CNSX:GTII), Cresco Labs (CNSX:CL) and Jushi Holdings (OTCMKTS:JUSHF) have returned 370%, 328%, and 498%, respectively, in the last 12 months, as seen in the below chart.

While Canadian marijuana producers are grappling with massive losses and decelerating revenue growth, the above-mentioned companies are on the cusp of profitability. The legalization of cannabis at the federal level in the U.S. is expected to be a massive tailwind for pot producers.

Let’s see why these three stocks might continue to outperform in 2021 as well.

Green Thumb Industries

In the fourth quarter of 2020, Green Thumb Industries reported revenue of $177.2 million, indicating year-over-year growth of 134% compared to revenue of $75.8 million in the prior-year period.

JUSH Chart

JUSH data by YCharts.

 It reported a GAAP net income of $22.5 million, or $0.11 per share, compared to a net loss of $14.1 million, or $0.07 per share, in Q4 of 2019. Comparatively, analysts expected Green Thumb to report sales of $167.2 million and earnings of $0.06 per share in the December quarter.

It generated an adjusted EBITDA of $65.4 million, which was up 23% sequentially and 374% higher than the prior-year period. Green Thumb reported a positive operating cash flow in each of the four quarters, as its operating expenses rose by just 14% year over year.

One of the key drivers of top-line growth for GTII was the opening of 11 retail cannabis stores in the last year and it ended Q4 with 51 stores in 10 states.

Cresco Labs

Cresco Labs disclosed its Q4 results last month and reported revenue of $162.3 million, which was a 300% increase compared to Q4 of 2019. It was the company’s best-performing quarter to date in terms of revenue. However, this stellar growth in sales did not translate into profits, as Cresco’s net loss stood at $24.4 million.

In Q3 of 2020, Cresco reported a net profit of $4.9 million while in Q4 of 2019, its net loss was significantly higher at $45.2 million. Comparatively, analysts expected Cresco to report sales of $161.4 million and earnings of $0.02 per share in Q4.

Its adjusted EBITDA rose from just $2.9 million in the prior-year period to $50 million in the December quarter. The cannabis multi-state operator ended the year with a cash balance of $136.3 million.

One of the major drivers of Cresco’s revenue growth was its acquisition of Origin House that was completed in January 2020.

Jushi Holdings

This cannabis and hemp company engages in the cultivation and distribution of medical and adult-use marijuana products. Jushi Holdings is focused on creating a portfolio of cannabis and hemp-derived assets in several states in the U.S.

Last month, Jushi opened its 17th retail cannabis store. It now has 11 stores in Pennsylvania, which is one of the fastest-growing pot markets in the country.

In the March quarter, Jushi has forecast revenue to grow by 365% to $40 million. In 2021, it expects revenue between $205 million and $255 million compared to sales of $80.6 million in 2020.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »